
Redmile Group
North America, California, United States, San Francisco
Description
Redmile Group is a healthcare investment organization that makes venture, growth, and crossover investing across healthcare.
Investor Profile
Redmile Group has made 182 investments, with 14 in the past 12 months and 26% as lead.
Stage Focus
- Series B (23%)
- Post Ipo Equity (22%)
- Series C (21%)
- Series A (10%)
- Series Unknown (9%)
- Series D (7%)
- Series E (3%)
- Private Equity (2%)
- Seed (1%)
- Series F (1%)
Country Focus
- United States (80%)
- United Kingdom (6%)
- Canada (3%)
- France (3%)
- Germany (2%)
- Switzerland (2%)
- Australia (2%)
- Belgium (1%)
- Sweden (1%)
- China (1%)
Industry Focus
- Biotechnology
- Health Care
- Therapeutics
- Medical
- Pharmaceutical
- Life Science
- Biopharma
- Health Diagnostics
- Medical Device
- Genetics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.